Edward Kent

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

Marcus Maurer, Luís Felipe Ensina, Ana M. Giménez‐Arnau et al. · The Lancet · 2023 · 64 citations

Life Sciences, Dermatology, Pharmacotherapy +8

Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment

Robert L. Jacobs, Philip Lieberman, Edward Kent et al. · Allergy and Asthma Proceedings · 2009 · 47 citations

Life Sciences, Pharmacology, Pharmacotherapy +17